> The President's prize evening
> Tuesday 4 March 2003
> The Royal Society of Medicine, 1 Wimpole Street, London W1G 0AE
>
> 4.45 pm Registration
>
> 5.00 pm Beta6-integrin cytoplasmic tail: novel intracellular target
> for inhibiting carcinoma invasion
> Dr Mark Morgan
> Cancer Research UK Laboratories, St Thomas'
> Hospital, London
>
> 5.15 pm Classical Hodgkin Lymphoma is associated with frequent gains
> of chromosome 17q
> Dr Daniel Chui
> Leukaemia Research Fund Virus Centre, University of
> Glasgow
>
> 5.30 pm Epidermal growth factor: a novel monocyte chemotactic factor
> and macrophage mitogen
> Dr David Lamb
> Centre for Clinical Science & Measurement,
> University of Surrey
>
> 5.45 pm Use of pLDH for the diagnosis and monitoring of patients
> infected with Plasmodium falciparum and its usefulness to determine the
> minimal inhibitory concentration for Quinine, Chloroquine, Amodiaquine,
> Mefloquine and Sulfadoxine/Pyremethamine from MARKIII culture supernatant
> compared with culture schizont inhibition count in 12 patients with
> infection
> Dr Helmut Schuster
> Clinical Microbiology, University College London
> Hospitals
>
> 6.00 pm Herpes simplex virus type 1 infection associated with atrial
> myxoma
> Dr Yanwen Li
> Division of Biomedical Sciences, Imperial College
> Faculty of Medicine, London
>
> 6.15 pm Screening for the TPMT gene mutations in South Africa
> Chemical Pathology
> North West London Hospitals NHS Trust
>
> 6.30 pm Reception
>
> 7.15 pm Announcement of winners
>
> 7.30 pm Close of meeting
>
> CME/CPD: 2 credits
> please contact:
>
> Claire Bowen
> tel: 44 (0)20 7290 3859
> Fax: 44 (0)20 7290 2989
> Email:[log in to unmask]
> www.rsm.ac.uk/pathology
>
***************** Important Notice - Disclaimer **************************
This email is from the Royal Society of Medicine,
Registered Charity No:- 206219
This email and any attachments may contain confidential information and/or
copyright material. This email is intendedfor the use of the addressee only.
Anyunauthorised use may be unlawful. If you receive this email by mistake,
please advise the sender immediately by using the reply facility in your
email software and then delete the message. Email sent to the RSM may be
monitored in line with current legislation and good practice.
**************************************************************************
------ACB discussion List Information--------
This is an open discussion list for the academic and clinical
community working in clinical biochemistry.
Please note, archived messages are public and can be viewed
via the internet. Views expressed are those of the individual and
they are responsible for all message content.
ACB Web Site
http://www.acb.org.uk
List Archives
http://www.jiscmail.ac.uk/lists/ACB-CLIN-CHEM-GEN.html
List Instructions (How to leave etc.)
http://www.jiscmail.ac.uk/
|